News

News Archive

Verseon presents second anticoagulation candidate for clinical trials at AHA 2017 Verseon presents second anticoagulation candidate for clinical trials at AHA 2017

Verseon presented preclinical data on its second anticoagulant candidate, VE-2851, at this week’s American Heart Association conference. VE 2851 shows excellent efficacy paired with low bleeding risk in preclinical testing and is expected to enter clinical trials in 2018.

Dr Peter Simpson Appointed to SLAS Board of Directors Dr Peter Simpson Appointed to SLAS Board of Directors

Dr Peter Simpson, Medicines Discovery Catapult’s Chief Scientific Officer, has been elected to the Board of Directors at the Society for Laboratory Automation and Screening (SLAS), the world’s pre-eminent community of life sciences professionals working to advance research through the use of technology.

HTC analytical conference comes to the UK HTC analytical conference comes to the UK

The 15th International Symposium on Hyphenated Techniques in Chromatography and Separation Technology (HTC-15) will take place in Cardiff from 24th to 26th January 2018. This will be just the second time in HTC's history that the event has taken place in the UK, and it will be the premier UK analytical meeting in 2018, attracting national and internationally renowned scientists.

Improving clinical trials with machine learning Improving clinical trials with machine learning

Machine learning could improve our ability to determine whether a new drug works in the brain, potentially enabling researchers to detect drug effects that would be missed entirely by conventional statistical tests, finds a new UCL study published on 13th November in Brain.

First clinical study patient has novel drug delivery system implanted for Parkinson’s trial First clinical study patient has novel drug delivery system implanted for Parkinson’s trial

On November 8th, 2017 the first patient in a new clinical study was implanted with a novel drug delivery system, developed by Renishaw, The procedure took place at Karolinska University Hospital in Stockholm, Sweden. The implantation marks the beginning of a joint clinical study between Renishaw and Herantis Pharma. This phase I - II clinical study will investigate the treatment of Parkinson’s disease using Cerebral Dopamine Neurotrophic Factor (CDNF) delivered with Renishaw’s system.

Professor Greg Hannon to Become Director of the Cancer Research UK Cambridge Institute Professor Greg Hannon to Become Director of the Cancer Research UK Cambridge Institute

Cancer Research UK and the University of Cambridge are pleased to announce the appointment of Professor Greg Hannon as the new director of the Cancer Research UK Cambridge Institute, today (Thursday).

New charity-industry initiative to pioneer novel approach to Health Technology Assessment New charity-industry initiative to pioneer novel approach to Health Technology Assessment

‘HERCULES’ project will for the first time generate and share critical disease level data across an entire condition on behalf of all collaborating companies, simplifying all future submissionsNew approach has the potential to improve the chances of medicines in rare and orphan diseases receiving positive decisions

The Pistoia Alliance AbVance Project Reaches a Key Milestone with First Release of Antibody Structures into the Protein Data Bank The Pistoia Alliance AbVance Project Reaches a Key Milestone with First Release of Antibody Structures into the Protein Data Bank

The AbVance project aims to accelerate biologics drug discovery by increasing knowledge of antibody structures in the public domain

National Physical Laboratory and Imperial College London launch new virtual lab to establish the UK Centre for Engineering Biology, Metrology and Standards National Physical Laboratory and Imperial College London launch new virtual lab to establish the UK Centre for Engineering Biology, Metrology and Standards

NPL, the UK’s National Measurement Institute (NMI), and SynbiCITE at Imperial College London, has announced the establishment of a new £7 million virtual lab to underpin their joint Centre for Engineering Biology, Metrology and Standards to help the UK synthetic biology industry improve the manufacturing and adoption of new products – in partnership with LGC and NIBSC.

Major Networking Career Opportunity for Young Women in the South West of England Major Networking Career Opportunity for Young Women in the South West of England

A major networking opportunity for young women seeking a career in Science, Technology, Engineering and Maths (STEM) is due to be held at Dartmoor Zoo in November.

Unique collaboration opportunities available for UK SMEs working on drug discovery Unique collaboration opportunities available for UK SMEs working on drug discovery

Medicines Discovery Catapult, a new national centre established to support innovative drug discovery, is inviting UK SMEs working in medicines to collaborate on high-resolution analysis.